Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences

/PRNewswire/ -- Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced the completion of the patient enrollment for the 600 mg dose cohort from...

Related Keywords

Sweden ,Julie Silber ,Aptevo Therapeutics Inc ,Shanghai Henlius Biotech Inc ,Orion Corporation ,Biotheus Inc ,Nasdaq Stockholm ,Shanghai Henlius Biotech ,Alligator Bioscience ,